227 related articles for article (PubMed ID: 16285477)
21. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
22. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.
Aguilar-Martinez P; Grandchamp B; Cunat S; Cadet E; Blanc F; Nourrit M; Lassoued K; Schved JF; Rochette J
Haematologica; 2011 Apr; 96(4):507-14. PubMed ID: 21228038
[TBL] [Abstract][Full Text] [Related]
23. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
24. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.
Simsek H; Balaban YH; Yilmaz E; Sumer H; Buyukasik Y; Cengiz C; Ozcebe O; Hascelik G; Tatar G
Ann Hematol; 2005 Oct; 84(10):646-9. PubMed ID: 15871018
[TBL] [Abstract][Full Text] [Related]
25. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis.
Burt MJ; Upton JD; Morison IM; Chapman BA; Faed JM; George PM
N Z Med J; 1997 Nov; 110(1056):429-32. PubMed ID: 9418837
[TBL] [Abstract][Full Text] [Related]
27. Genetics of hemochromatosis.
Cullen LM; Anderson GJ; Ramm GA; Jazwinska EC; Powell LW
Annu Rev Med; 1999; 50():87-98. PubMed ID: 10073265
[TBL] [Abstract][Full Text] [Related]
28. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
[TBL] [Abstract][Full Text] [Related]
29. HFE gene mutations in coronary atherothrombotic disease.
Calado RT; Franco RF; Pazin-Filho A; Simões MV; Marin-Neto JA; Zago MA
Braz J Med Biol Res; 2000 Mar; 33(3):301-6. PubMed ID: 10719381
[TBL] [Abstract][Full Text] [Related]
30. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression.
Distante S; Berg JP; Lande K; Haug E; Bell H
Scand J Gastroenterol; 1999 May; 34(5):529-34. PubMed ID: 10423072
[TBL] [Abstract][Full Text] [Related]
32. HFE based re-evaluation of heterozygous hemochromatosis.
Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
[TBL] [Abstract][Full Text] [Related]
34. Haemochromatosis: automated detection of the two point mutations in the HFE gene: Cys282Tyr and His63Asp.
Klingler KR; Zech D; Wielckens K
Clin Chem Lab Med; 2000 Dec; 38(12):1225-30. PubMed ID: 11205685
[TBL] [Abstract][Full Text] [Related]
35. [The prevalence of the Cys282Tyr mutation in the hemochromatosis gene in Cantabria in patients diagnosed with hereditary hemochromatosis].
Fábrega E; Castro B; Sánchez-Castro L; Benito A; Fernández-Luna JL; Pons-Romero F
Med Clin (Barc); 1999 Apr; 112(12):451-3. PubMed ID: 10320958
[TBL] [Abstract][Full Text] [Related]
36. Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes.
Mariani R; Pelucchi S; Arosio C; Coletti S; Pozzi M; Paolini V; Trombini P; Piperno A
Blood Cells Mol Dis; 2010 Mar; 44(3):159-63. PubMed ID: 20117027
[TBL] [Abstract][Full Text] [Related]
37. A population-based study of the clinical expression of the hemochromatosis gene.
Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
[TBL] [Abstract][Full Text] [Related]
38. Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data.
Scotet V; Le Gac G; Mérour MC; Mercier AY; Chanu B; Ka C; Mura C; Nousbaum JB; Férec C
BMC Med Genet; 2005 Jun; 6():24. PubMed ID: 15929798
[TBL] [Abstract][Full Text] [Related]
39. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic.
Kratka K; Dostalikova-Cimburova M; Michalikova H; Stransky J; Vranova J; Horak J
Br J Dermatol; 2008 Sep; 159(3):585-90. PubMed ID: 18565178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
